{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:17:17Z","timestamp":1754558237508},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,15]]},"DOI":"10.7759\/cureus.33809","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T07:31:05Z","timestamp":1673854265000},"source":"Crossref","is-referenced-by-count":2,"title":["Adverse Drug Interaction Between Kratom and Amitriptyline With Gastrointestinal and Mild Hepatic Effects"],"prefix":"10.7759","author":[{"given":"Naisarg B","family":"Vanani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: A comprehensive review","volume":"9","author":"Eastlack SC","year":"2020","unstructured":"Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: A comprehensive review. Pain Ther. 2020, 9:55-69. 10.1007\/s40122-020-00151-x","journal-title":"Pain Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/968786","article-title":"Following \"the roots\" of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries","volume":"2015","author":"Cinosi E","year":"2015","unstructured":"Cinosi E, Martinotti G, Simonato P, et al.. Following \"the roots\" of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries. Biomed Res Int. 2015, 2015:968786. 10.1155\/2015\/968786","journal-title":"Biomed Res Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hermed.2019.100293","article-title":"Improved sexual functioning of long-term daily users of Mitragyna speciosa (Korth.)","volume":"19","author":"Singh D.","year":"2020","unstructured":"Singh D., Grundmann O., Murugaiyah V., et al.. Improved sexual functioning of long-term daily users of Mitragyna speciosa (Korth.). Journal of Herbal Medicine. 2020, 19:100293. 10.1016\/j.hermed.2019.100293","journal-title":"Journal of Herbal Medicine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6529a4","article-title":"Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers - United States, 2010-2015","volume":"65","author":"Anwar M","year":"2016","unstructured":"Anwar M, Law R, Schier J. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016, 65:748-9. 10.15585\/mmwr.mm6529a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.02.004","article-title":"Past-year Kratom use in the U.S.: Estimates from a nationally representative sample","volume":"61","author":"Palamar JJ","year":"2021","unstructured":"Palamar JJ. Past-year Kratom use in the U.S.: Estimates from a nationally representative sample. Am J Prev Med. 2021, 61:240-5. 10.1016\/j.amepre.2021.02.004","journal-title":"Am J Prev Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20191112-03","article-title":"Kratom: Implications for health care providers","volume":"57","author":"Goldin D","year":"2019","unstructured":"Goldin D, Salani D, Mckay M. Kratom: Implications for health care providers. J Psychosoc Nurs Ment Health Serv. 2019, 57:15-20. 10.3928\/02793695-20191112-03","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh D","year":"2014","unstructured":"Singh D, M\u00fcller CP, Vicknasingam BK. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend. 2014, 139:132-7. 10.1016\/j.drugalcdep.2014.03.017","journal-title":"Drug Alcohol Depend"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011-2017","volume":"57","author":"Post S","year":"2019","unstructured":"Post S, Spiller HA, Chounthirath T, Smith GA. Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol (Phila). 2019, 57:847-54. 10.1080\/15563650.2019.1569236","journal-title":"Clin Toxicol (Phila)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14679","article-title":"Kratom-induced liver injury: A case series and clinical implications","volume":"13","author":"Botejue M","year":"2021","unstructured":"Botejue M, Walia G, Shahin O, Sharma J, Zackria R. Kratom-induced liver injury: A case series and clinical implications. Cureus. 2021, 13:e14679. 10.7759\/cureus.14679","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2019.11.005","article-title":"Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids","volume":"319","author":"Kamble SH","year":"2020","unstructured":"Kamble SH, Sharma A, King TI, et al.. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids. Toxicol Lett. 2020, 319:148-54. 10.1016\/j.toxlet.2019.11.005","journal-title":"Toxicol Lett"},{"key":"ref11","article-title":"Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype","author":"Dean L","year":"2017","unstructured":"Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. 2017."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2012.112.12.792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","author":"Prozialeck WC","year":"2012","unstructured":"Prozialeck WC, Jivan JK, Andurkar SV. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc. 2012, 10.7556\/jaoa.2012.112.12.792","journal-title":"J Am Osteopath Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01296-8","article-title":"Adverse drug reactions associated with amitriptyline\u00a0-\u00a0protocol for a systematic multiple-indication review and meta-analysis","volume":"9","author":"Brueckle MS","year":"2020","unstructured":"Brueckle MS, Thomas ET, Seide SE, et al.. Adverse drug reactions associated with amitriptyline\u00a0-\u00a0protocol for a systematic multiple-indication review and meta-analysis. Syst Rev. 2020, 9:59. 10.1186\/s13643-020-01296-8","journal-title":"Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2011.04.011","article-title":"Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E\u2082 production induced by lipopolysaccharide in RAW264.7 macrophage cells","volume":"136","author":"Utar Z","year":"2011","unstructured":"Utar Z, Majid MI, Adenan MI, Jamil MF, Lan TM. Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E\u2082 production induced by lipopolysaccharide in RAW264.7 macrophage cells. J Ethnopharmacol. 2011, 136:75-82. 10.1016\/j.jep.2011.04.011","journal-title":"J Ethnopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto K","year":"1996","unstructured":"Matsumoto K, Mizowaki M, Suchitra T, et al.. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. European Journal of Pharmacology. 1996, 317:75-81. 10.1016\/s0014-2999(96)00714-5","journal-title":"European Journal of Pharmacology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.08.013","article-title":"Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","volume":"549","author":"Matsumoto K","year":"2006","unstructured":"Matsumoto K, Hatori Y, Murayama T, et al.. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Eur J Pharmacol. 2006, 549:63-70. 10.1016\/j.ejphar.2006.08.013","journal-title":"Eur J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1389450121666200719011653","article-title":"Kratom dependence and treatment options: A comprehensive review of the literature","volume":"21","author":"Bin Abdullah MF","year":"2020","unstructured":"Bin Abdullah MF. Kratom dependence and treatment options: A comprehensive review of the literature. Curr Drug Targets. 2020, 21:1566-79. 10.2174\/1389450121666200719011653","journal-title":"Curr Drug Targets"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22864","article-title":"Anesthetic challenges posed by heavy Kratom users","volume":"14","author":"Lund E","year":"2022","unstructured":"Lund E, Low AB, Allan JD, Puentes JA, Flynn DN. Anesthetic challenges posed by heavy Kratom users. Cureus. 2022, 14:e22864. 10.7759\/cureus.22864","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131415-adverse-drug-interaction-between-kratom-and-amitriptyline-with-gastrointestinal-and-mild-hepatic-effects","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:47Z","timestamp":1707508127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131415-adverse-drug-interaction-between-kratom-and-amitriptyline-with-gastrointestinal-and-mild-hepatic-effects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.33809","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}